Post-marketing surveillance (PMS) on long-term use of tiotropium+olodaterol fixed dose combination (Tio+Olo FDC) 5/5µg in patients with chronic obstructive pulmonary disease (chronic bronchitis, emphysema) in Japan (Japanese Spiolt PMS, long term) First published 21/07/2016 Last updated 17/12/2025 EU PAS number:EUPAS14273 Study Finalised